114 related articles for article (PubMed ID: 25525853)
1. Upregulated genes at 2q24 gains as candidate oncogenes in hepatoblastomas.
Rodrigues TC; Fidalgo F; da Costa CM; Ferreira EN; da Cunha IW; Carraro DM; Krepischi AC; Rosenberg C
Future Oncol; 2014 Dec; 10(15):2449-57. PubMed ID: 25525853
[TBL] [Abstract][Full Text] [Related]
2. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis.
Kumon K; Kobayashi H; Namiki T; Tsunematsu Y; Miyauchi J; Kikuta A; Horikoshi Y; Komada Y; Hatae Y; Eguchi H; Kaneko Y
Jpn J Cancer Res; 2001 Aug; 92(8):854-62. PubMed ID: 11509117
[TBL] [Abstract][Full Text] [Related]
3. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization analysis of hepatoblastomas.
Hu J; Wills M; Baker BA; Perlman EJ
Genes Chromosomes Cancer; 2000 Feb; 27(2):196-201. PubMed ID: 10612809
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21.
Tomlinson GE; Douglass EC; Pollock BH; Finegold MJ; Schneider NR
Genes Chromosomes Cancer; 2005 Oct; 44(2):177-84. PubMed ID: 15981236
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas.
Stejskalová E; Malis J; Snajdauf J; Pýcha K; Urbánková H; Bajciová V; Starý J; Kodet R; Jarosová M
Cancer Genet Cytogenet; 2009 Oct; 194(2):82-7. PubMed ID: 19781440
[TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas.
Gray SG; Kytölä S; Matsunaga T; Larsson C; Ekström TJ
Br J Cancer; 2000 Oct; 83(8):1020-5. PubMed ID: 10993649
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic findings in two new cases of hepatoblastoma.
Ali W; Savasan S; Rabah R; Mohamed AN
Cancer Genet Cytogenet; 2002 Mar; 133(2):179-82. PubMed ID: 11943350
[TBL] [Abstract][Full Text] [Related]
11. FOXG1 is overexpressed in hepatoblastoma.
Adesina AM; Nguyen Y; Guanaratne P; Pulliam J; Lopez-Terrada D; Margolin J; Finegold M
Hum Pathol; 2007 Mar; 38(3):400-9. PubMed ID: 17217994
[TBL] [Abstract][Full Text] [Related]
12. Significance of extra copies of chromosome 20 and the long arm of chromosome 2 in hepatoblastoma.
Swarts S; Wisecarver J; Bridge JA
Cancer Genet Cytogenet; 1996 Oct; 91(1):65-7. PubMed ID: 8908169
[TBL] [Abstract][Full Text] [Related]
13. Consistent cytogenetic aberrations in hepatoblastoma: a common pathway of genetic alterations in embryonal liver and skeletal muscle malignancies?
Fletcher JA; Kozakewich HP; Pavelka K; Grier HE; Shamberger RC; Korf B; Morton CC
Genes Chromosomes Cancer; 1991 Jan; 3(1):37-43. PubMed ID: 1648956
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
15. [Genomic imbalance and chromosome disorders in hepatoblastoma].
Gao H; Zhang ZB; Ou YL; Zhang KR; Wang WL
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):915-9. PubMed ID: 17533743
[TBL] [Abstract][Full Text] [Related]
16. Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas.
Gray SG; Hartmann W; Eriksson T; Ekstrom C; Holm S; Kytola S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekstrom TJ
Int J Mol Med; 2000 Aug; 6(2):161-9. PubMed ID: 10891560
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic abnormalities and clonal evolution in an adult hepatoblastoma.
Parada LA; Bardi G; Hallén M; Hägerstrand I; Tranberg KG; Mitelman F; Johansson B
Am J Surg Pathol; 1997 Nov; 21(11):1381-6. PubMed ID: 9351578
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
19. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma.
Albrecht S; von Schweinitz D; Waha A; Kraus JA; von Deimling A; Pietsch T
Cancer Res; 1994 Oct; 54(19):5041-4. PubMed ID: 7923113
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic abnormalities in hepatoblastoma: report of two new cases and review of the literature suggesting imbalance of chromosomal regions on chromosomes 1, 4, and 12.
Nagata T; Nakamura M; Shichino H; Chin M; Sugito K; Ikeda T; Koshinaga T; Fukuzawa M; Inoue M; Mugishima H
Cancer Genet Cytogenet; 2005 Jan; 156(1):8-13. PubMed ID: 15588850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
